Mobocertinib is under clinical development by Takeda Pharmaceutical and currently in Phase I for Duodenal Cancer.

The Duodenal Cancer drugs in development market research report provides comprehensive information on the therapeutics under development for Duodenal Cancer, complete with analysis by stage of ...

The Fourways community raised over R200,000 to bring Dr Domingo Alvear to South Africa to perform his pioneering surgery on a ...

Seven duodenal ulcers were found, two in patients with normal pancreatic function (2/52 = 3.8%; 95% conf lim: 0.5-13.2) and five in patients with reduced pancreatic function (5/20 = 25%; 95% conf lim: ...

Frequent burping, often due to alcohol, acid reflux, or gastrointestinal issues, can be managed by lifestyle changes and ...

Perforation is the rarest complication of duodenal diverticulum but also one of its most serious complications. Mortality rate was reported to up to 30%. Clinical diagnosis is usually vague and ...

Duodenal mucosal resurfacing (DMR) is an endoscopic procedure where the duodenal mucosa is ablated to treat type 2 diabetes. DMR leads to improved glycaemia and additional metabolic improvements, such ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A teenage girl who was left to die watching the TV quiz show Tipping Point was 'exposed' to her mum having sex with men in ...